Why would you say that this will not exceed the sales of Celebrex? By removing the black box warning, you are opening the door for more revenue, or at least the same even with a lower price per pill. Also more and more people experience pain from OA. Unless there is a complete cure for OA, there will always be a need for pain management.
Celebrex sales are declining, but from what you seem to think is because no one has OA anymore, or am I reading this incorrectly? Sales are declining from generic erosion, not because there is no need. Kit 302 will take market share away from generic Celebrex as well.
Pfizer has no choice....Celebrex is done in 3-5years to barely be in the black. This pill will be used to phase out the dying sales with new life for the next 8-9 years.
Look, we are both obviously bullish here, just trying to get everyone to open their eyes on what seems to me a very realistic outcome.
News 
Market Data 
Discover 
